Biotech Investment Analyst – Drug Asset & Company Assessment

🔥 0 minutes ago

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

Mercor

WebsiteLinkedInAll Job Openings

51 - 200 employees

Founded 2023

🔥 Funding within the last year

💰 $350M Series C - Mercor on 2025-10

Mercor is a company for which no descriptive text was provided in the input. Additional information (products, services, target customers, or industry specifics) is needed to create an accurate summary and select appropriate industries.

📋 Description

• Create and critique rubrics that analyze commercial drugs and drug-development programs • Provide overall company and asset assessment, including mechanism, clinical data, competitive position, and value drivers • Judge the quality of an investment-style thesis • Flag weak, overconfident, or missing assumptions • Apply assessments across approximately 5–10 companies during the pilot • Participate in a paid 10–20 hour pilot over 1–2 weeks • Work on projects focused on training and enhancing AI systems

🎯 Requirements

• US-based biotech / healthcare investment analyst • Specialist-fund background • Familiarity with biotech/pharma development programs • Ability to assess a drug asset and the company behind it end-to-end • 5+ years evaluating biotech/pharma companies or assets • Unable to support H1-B or STEM OPT candidates at this time • Independent contractor engagement

🏖️ Benefits

• Recurring engagement for strong contributors • Fully remote role • Flexible schedule / completed on your own schedule • Weekly payments on Stripe or Wise based on services rendered • Potential to continue as the work scales • Projects can be extended, shortened, or concluded early depending on needs and performance • Reasonable accommodations upon request • Referral payments of up to $800 for each successful referral